ArticleFrontiers in psychology2025
Case Report: Multi-modal motion-assisted memory desensitization and reconsolidation for traumatic grief (3MDR-TG).
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The loss of a loved one under traumatic circumstances puts bereaved individuals at risk of developing prolonged grief disorder (PGD), (symptoms of) posttraumatic stress disorder (PTSD) and major depressive disorder (MDD), also referred to as traumatic grief. Traumatic grief is often associated with high symptom levels and strong avoidance. Not all patients benefit from standard treatments. Multi-modal Motion-assisted Memory Desensitization and Reconsolidation (3MDR) has shown to be effective in the treatment of treatment-resistant PTSD. The development of a 3MDR protocol specifically for Traumatic Grief protocol (3MDR-TG) enables grief-focused exposure in an immersive, personalized and activating context. Objective: To provide a proof-of-concept of 3MDR-TG for traumatically bereaved individuals with PGD and PTSD. Method: 3MDR-TG was applied to a bereaved mother after the traumatic loss of her daughter. Qualitative interviews with the patient and the therapists were conducted to determine feasibility and acceptability. Clinician-rated PTSD, PGD and MDD symptoms were assessed at baseline, after 3MDR-TG, and at 16-week follow-up (primary endpoint). Results: The patient and therapists experienced the treatment as feasible and acceptable and rated the credibility of the treatment as high. Although some symptoms temporarily increased following exposure sessions, the overall decrease in PTSD, PGD and depressive symptom severity from baseline to primary endpoint (16 weeks follow-up) corresponded with reliable changes for PGD (RCI = -2.74), PTSD (RCI = -3.05) and depression (RCI = -3.05). Conclusion: We observed a clinically relevant and reliable decrease in PTSD, PGD and depressive symptoms over the course of 3MDR-TG. Further studies of 3MDR-TG in patients with traumatic grief are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.